Manuel Adrian Acuña-Zegarra

Dr. Manuel Adrian Acuña-Zegarra

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Mathematical Biosciences
Verified
Journal Article
Closed access
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
MSMario Santana-Cibrian
Mario Santana-Cibrian
JVJorge X. Velasco-Hernandez
Jorge X. Velasco-Hernandez

1 July 2021 in Mathematical Biosciences
Verified
Journal Article
Closed access
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
SDSaúl Díaz-Infante
Saúl Díaz-Infante
DBDavid Baca-Carrasco
David Baca-Carrasco
DODaniel Olmos-Liceaga
Daniel Olmos-Liceaga

1 November 2018 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
DODaniel Olmos-Liceaga
Daniel Olmos-Liceaga
JVJorge X. Velasco-Hernández
Jorge X. Velasco-Hernández

1 January 2020 in Mathematical Biosciences and Engineering
Verified
Journal Article
Open access
PDF file
MSMario Santana-Cibrian
Mario Santana-Cibrian
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
JVJorge X Velasco-Hernandez
Jorge X Velasco-Hernandez
SARS-CoV-2 has now infected 15 million people and produced more than six hundred thousand deaths around the world. Due to high transmission levels, many governments implemented social distancing and confinement measures with different levels of required compliance to mitigate the COVID-19 epidemic. In several countries, these measures were effective, and it was possible to flatten the epidemic curve and control it. In others, this objective was not or has not been achieved. In far too many cities around the world, rebounds of the epidemic are occurring or, in others, plateaulike states have appeared, where high incidence rates remain constant for relatively long periods of time. Nonetheless, faced with the challenge of urgent social need to reactivate their economies, many countries have decided to lift mitigation measures at times of high incidence. In this paper, we use a mathematical model to characterize the impact of short duration transmission events within the confinement period previous but close to the epidemic peak. The model also describes the possible consequences on the disease dynamics after mitigation measures are lifted. We use Mexico City as a case study. The results show that events of high mobility may produce either a later higher peak, a long plateau with relatively constant but high incidence or the same peak as in the original baseline epidemic curve, but with a post-peak interval of slower decay. Finally, we also show the importance of carefully timing the lifting of mitigation measures. If this occurs during a period of high incidence, then the disease transmission will rapidly increase, unless the effective contact rate keeps decreasing, which will be very difficult to achieve once the population is released.

3 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMayra R. Tocto-Erazo
Mayra R. Tocto-Erazo
JEJorge A. Espíndola-Zepeda
Jorge A. Espíndola-Zepeda
JMJosé A. Montoya-Laos
José A. Montoya-Laos
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
DODaniel Olmos-Liceaga
Daniel Olmos-Liceaga
GFGudelia Figueroa-Preciado
Gudelia Figueroa-Preciado
Lockdown and social distancing measures have been implemented for many countries to mitigate the impacts of the COVID-19 pandemic and prevent overwhelming of health services. However, success on this strategy depends not only on the timing of its implementation, but also on the relaxation measures adopted within each community. We developed a mathematical model to evaluate the impacts of the lockdown implemented in Hermosillo, Mexico. We compared this intervention with some hypothetical ones, varying the starting date and also the population proportion that is released, breaking the confinement. A Monte Carlo study was performed by considering three scenarios to define our baseline dynamics. Results showed that a hypothetical delay of two weeks, on the lockdown measures, would result in an early acme around May 9 for hospitalization prevalence and an increase on cumulative deaths, 42 times higher by May 31, when compared to baseline. On the other hand, results concerning relaxation dynamics showed that the acme levels depend on the proportion of people who gets back to daily activities as well as the individual behavior with respect to prevention measures. Analysis regarding different relaxing mitigation measures were provided to the Sonoran Health Ministry, as requested. It is important to stress that, according to information provided by health authorities, the acme occurring time was closed to the one given by our model. Hence, we considered that our model resulted useful for the decision-making assessment, and that an extension of it can be used for the study of a potential second wave.

20 November 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MAManuel Adrian Acuña-Zegarra
Manuel Adrian Acuña-Zegarra
SDSaúl Díaz-Infante
Saúl Díaz-Infante
DBDavid Baca-Carrasco
David Baca-Carrasco
DLDaniel Olmos Liceaga
Daniel Olmos Liceaga
At the date, Europe and part of North America face the second wave of COVID-19, causing more than 1 300 000 deaths worldwide. Humanity lacks successful treatments, and a sustainable solution is an effective vaccine. Pfizer and the Russian Gamaleya Institute report that its vaccines reach more than 90 % efficacy in a recent press release. If third stage trial results favorable, pharmaceutical firms estimate big scale production of its vaccine candidates around the first 2021 quarter and the World Health organization fix as objective, vaccinate 20 % of the whole population at the final of 2021. However, since COVID-19 is new to our knowledge, vaccine efficacy and induced-immunity responses remain poorly understood. There are great expectations, but few think the first vaccines will be fully protective. Instead, they may reduce the severity of illness, reducing hospitalization and death cases. Further, logistic supply, economic and political implications impose a set of grand challenges to develop vaccination policies. For this reason, health decision-makers require tools to evaluate hypothetical scenarios and evaluate admissible responses. Our contribution answers questions in this direction. According to the WHO Strategic Advisory Group of Experts on Immunization Working Group on COVID-19 Vaccines, we formulate an optimal controlled model to describe vaccination policies that minimize the burden of COVID-19 quantified by the number of disability-adjusted years of life lost. Additionally, we analyze the reproductive vaccination number according to vaccination profiles depending on coverage, efficacy, horizon time, and vaccination rate. We explore scenarios regarding efficacy, coverage, vaccine-induced immunity, and natural immunity via numerical simulation. Our results suggest that response regarding vaccine-induced immunity and natural immunity would play a dominant role in the vaccination policy design. Likewise, the vaccine efficacy would influence the time of intensifying the number of doses in the vaccination policy.